Methylation and Mrna Expression of Imprinted Gene SLC22A18/TSSC5/BWR1A in Breast Cancer

徐红梅,张宏伟,贺黉裕,侯英勇,赵子琴
DOI: https://doi.org/10.3321/j.issn:1000-4718.2008.05.035
2008-01-01
Abstract:AIM:To study the mRNA expression and methylation status of imprinted gene SLC22A18 in infiltrating ductal carcinomas(IDCs),and the correlation between methylation status and clinical characteristics in IDCs.METHODS:The methylation status at the promoter regions of SLC22A18 gene was examined by methylation-specific polymerase chain reaction(MSP)in the specimens of IDC from 40 patients.The mRNA expression of SLC22A18 gene was detected by real-time reverse quantitative transcriptase polymerase chain reaction(real-time RT-PCR)in 40 specimens of IDC and the cell line MDA-MB-231.The cell line MDA-MB-231 was treated with 5-aza-2'-deoxycytidine(5'-aza-dc)and trichostatin A(TSA),then MSP and rea1-time RT-PCR were used to detect the methylation status and mRNA expression levels of SLC22A18 gene.RESULTS:SLC22A18 mRNA expression in 40 IDC tissues was lower than that in al1 corresponding adjacent non-cancerous tissues(P0.01).By employing MSP the frequency of aberrant methylation for SLC22A18 in 40 IDCs samples and their corresponding adjacent non-cancerous tissues were determined.The percentages of methylation for SLC22A18 in 40 IDCs were 75% and in the corresponding adjacent non-cancerous tissues,37.5%,respectively.The frequency of methylation of SLC22A18 in 40 IDCs was higher than that in the corresponding adjacent non-cancerous tissues(75% vs 37.5%,P0.01).The mRNA expression of SLC22A18 gene in methylation group of IDCs was significantly reduced when compared with that in unmethylation group of IDCs(P0.01).After treated with 5-aza-dc and/or TSA,promoter methylation was detected in MDA-MB-231 cell line.The SLC22A18 promoter CpG island remained methylated in MDA-MB-231 cells treated with TSA,whereas the treatment with 5-aza-dc alone or in combination with TSA demethylated the SLC22A18 CpG island at various levels compared to the untreated control.In addition,MDA-MB-231 cells treated with 5-aza-dc and/or TSA produced an increased expression of SLC22A18 mRNA as detected by rea1-time RT-PCR.The combination therapy was more effective than either alone.In addition,MDA-MB-231 cells treated with 5-aza-dc and/or TSA produced an increased expression of SLC22A18 mRNA as detected by rea1-time RT-PCR.CONCLUSION:The reduced expression of SLC22A18 is associated with aberrant DNA methylation in the promoter region.
What problem does this paper attempt to address?